Cambrex sales decreased by 9.9% in Q4 2009 and full year sales were down 5.3% on 2008. The company said the decrease is primarily due to lower volumes of an API that utilises its polymeric drug delivery technology, lower sales of two APIs manufactured under long-term supply agreements and lower custom development revenues.
Cambrex
Saturday 13 February 2010
Cambrex sales decline in Q4
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment